Page last updated: 2024-08-22

camptothecin and naphthalimides

camptothecin has been researched along with naphthalimides in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (22.22)	18.2507
2000's	3 (33.33)	29.6817
2010's	3 (33.33)	24.3611
2020's	1 (11.11)	2.80

Authors

Authors	Studies
Diasio, RB; Stagg, MP	1
Burris, HA; Eckardt, JR; Fields, S; O'Rourke, T; Rodriguez, GI; Rothenberg, ML; Weiss, GR	1
Innocenti, F; Iyer, L; Ratain, MJ	2
Darro, F; Dewelle, J; Dumont, P; El Yazidi, M; Gaussin, JF; Kiss, R; Lefranc, F; Mahieu, T; Mijatovic, T; Ribaucour, F; Sauvage, S; Simon, G; Tuti, J; Van Quaquebeke, E; Van Vynckt, F	1
Bhuniya, S; Han, JH; Kang, C; Kim, JS; Kim, JY; Lee, MH; Sessler, JL	1
Ji, L; Li, S; Li, Z; Liu, S; Meng, X; Zhang, C	1
Hu, Y; Zeng, F	1
Liu, Y; Sheng, X; Wang, J; Zhang, YH; Zhang, YM	1

Reviews

3 review(s) available for camptothecin and naphthalimides

Article	Year
Novel chemotherapeutic agents in early clinical development. Current opinion in oncology, 1990, Volume: 2, Issue:6 Topics: Adenine; Alkaloids; Anthraquinones; Antineoplastic Agents; Biphenyl Compounds; Camptothecin; Humans; Imides; Irinotecan; Isoquinolines; Naphthalimides; Neoplasms; Organophosphonates; Paclitaxel; Pyrazoles; Quinazolines; Sulfonylurea Compounds; Terpenes; Trimetrexate	1990
New anticancer agents. Cancer chemotherapy and biological response modifiers, 1994, Volume: 15 Topics: Adenine; Animals; Antineoplastic Agents; Camptothecin; Deoxycytidine; Gemcitabine; Humans; Imides; Indoles; Irinotecan; Isoquinolines; Naphthalimides; Organophosphonates; Pyridines; Topotecan; Vinblastine; Vinorelbine	1994
Pharmacogenetics: a tool for individualizing antineoplastic therapy. Clinical pharmacokinetics, 2000, Volume: 39, Issue:5 Topics: Adenine; Antineoplastic Agents; Camptothecin; Dihydrouracil Dehydrogenase (NADP); Fluorouracil; Genotype; Glucuronosyltransferase; Humans; Imides; Irinotecan; Isoquinolines; Mercaptopurine; Methyltransferases; Naphthalimides; Organophosphonates; Oxidoreductases; Pharmacogenetics; Phenotype	2000

Trials

1 trial(s) available for camptothecin and naphthalimides

Article	Year
Novel chemotherapeutic agents in early clinical development. Current opinion in oncology, 1990, Volume: 2, Issue:6 Topics: Adenine; Alkaloids; Anthraquinones; Antineoplastic Agents; Biphenyl Compounds; Camptothecin; Humans; Imides; Irinotecan; Isoquinolines; Naphthalimides; Neoplasms; Organophosphonates; Paclitaxel; Pyrazoles; Quinazolines; Sulfonylurea Compounds; Terpenes; Trimetrexate	1990

Other Studies

6 other study(ies) available for camptothecin and naphthalimides

Article	Year
Pharmacogenetics of anticancer agents: lessons from amonafide and irinotecan. Drug metabolism and disposition: the biological fate of chemicals, 2001, Volume: 29, Issue:4 Pt 2 Topics: Adenine; Antineoplastic Agents; Camptothecin; Humans; Imides; Irinotecan; Isoquinolines; Naphthalimides; Organophosphonates; Pharmacogenetics; Polymorphism, Genetic	2001
2,2,2-Trichloro-N-({2-[2-(dimethylamino)ethyl]-1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinolin- 5-yl}carbamoyl)acetamide (UNBS3157), a novel nonhematotoxic naphthalimide derivative with potent antitumor activity. Journal of medicinal chemistry, 2007, Aug-23, Volume: 50, Issue:17 Topics: Acetamides; Adenine; Animals; Antineoplastic Agents; Apoptosis; Autophagy; Camptothecin; Cell Line, Tumor; Cellular Senescence; Deoxycytidine; Drug Screening Assays, Antitumor; Erythrocyte Count; Female; Gemcitabine; Humans; Imides; Irinotecan; Isoquinolines; Leukocyte Count; Maximum Tolerated Dose; Mice; Naphthalimides; Neoplasm Transplantation; Organophosphonates; Platelet Count; Structure-Activity Relationship; Topoisomerase I Inhibitors; Urea	2007
Direct fluorescence monitoring of the delivery and cellular uptake of a cancer-targeted RGD peptide-appended naphthalimide theragnostic prodrug. Journal of the American Chemical Society, 2012, Aug-01, Volume: 134, Issue:30 Topics: Antineoplastic Agents, Phytogenic; Camptothecin; Cell Line, Tumor; Cell Survival; Humans; Microscopy, Confocal; Naphthalimides; Neoplasms; Oligopeptides; Prodrugs	2012
Design, synthesis and antitumor activity of non-camptothecin topoisomerase I inhibitors. Bioorganic & medicinal chemistry letters, 2015, Oct-15, Volume: 25, Issue:20 Topics: Antineoplastic Agents; Camptothecin; Cell Line, Tumor; Cell Proliferation; DNA Topoisomerases, Type I; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Molecular Docking Simulation; Molecular Structure; Naphthalimides; Structure-Activity Relationship; Topoisomerase I Inhibitors	2015
A theranostic prodrug based on FRET for real-time drug release monitoring in response to biothiols. Materials science & engineering. C, Materials for biological applications, 2017, Mar-01, Volume: 72 Topics: Animals; Antineoplastic Agents; Camptothecin; Cell Line, Tumor; Cell Survival; Chromatography, High Pressure Liquid; Disulfides; Drug Carriers; Drug Liberation; Fluorescence Resonance Energy Transfer; Glutathione; HeLa Cells; Humans; Mass Spectrometry; Mice; Microscopy, Fluorescence; Naphthalimides; Prodrugs	2017
Enzyme-responsive fluorescent camptothecin prodrug/polysaccharide supramolecular assembly for targeted cellular imaging and in situ controlled drug release. Chemical communications (Cambridge, England), 2020, Jan-23, Volume: 56, Issue:7 Topics: Adamantane; Animals; Antineoplastic Agents; beta-Cyclodextrins; Camptothecin; Drug Carriers; Drug Liberation; Fluorescent Dyes; HCT116 Cells; Humans; Hyaluronic Acid; Mice; Microscopy, Confocal; Microscopy, Fluorescence; Naphthalimides; NIH 3T3 Cells; Prodrugs	2020